Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc. (ARQT) Stock Overview

Explore Arcutis Biotherapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ARQT●NASDAQ
HealthcareBiotechnology
$27.90
$0.36(1.27%)
U.S. Market opens in NaNh NaNm

Arcutis Biotherapeutics, Inc. (ARQT)

Meyka AI Score

Z

Key Financials

Market Cap3.5B
P/E Ratio-1454.95
EPS (TTM)$-0.03
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$28.59
3 Months$28.78
1 Year Target$31.46

ARQT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Arcutis Biotherapeutics, Inc. (ARQT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.34, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $31.46.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1454.95 and a market capitalization of 3.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.27%
5-Day Change
1.49%
1-Month Change
4.65%
3-Month Change
17.47%
6-Month Change
4.69%
Year-to-Date (YTD) Change
-3.93%
1-Year Change
91.75%
3-Year Change
170.87%
5-Year Change
11.82%
All-Time (Max) Change
27.98%

Contact Information

https://www.arcutis.com
805 418 5006
3027 Townsgate Road, Westlake Village, CA, 91361

Company Facts

3,540 Employees
IPO DateJan 31, 2020
CountryUS
Actively Trading

Frequently Asked Questions